Follow us on

wmedtour

Search
Close this search box.

Dr. IBRAHIM YILDIZ

About Dr. IBRAHIM YILDIZ

Education

  • 2013Istanbul University Istanbul Faculty of Medicine Medical Oncology
  • 2006Istanbul University Cerrahpaşa Medical Faculty Internal Medicine
  • 2003Istanbul University Cerrahpasa Medical Faculty

Experience

  • 2015Acıbadem Health Group
  • 2013 – 2015Izmir Katip Celebi University Ataturk Training and Research Hospital / Medical Oncology Clinic
  • 2009 – 2010War Academies Command / Military Service
  • 2007 – 2009Kağıthane State Hospital / Compulsory Service
Memberships

  • European Society of Medical Oncology
  • Lung Cancer Association Board Member
  • Turkish Medical Oncology Association
  • American Society of Clinical Oncology
PUBLICATIONS

  • Evaluation of c-kit (CD 117) expression as a prognostic factor in testicular germ cell tumors: An Izmir Oncology Group (IZOG) study.J BUON. 2015 Jul-Aug;20(4):1054-60 Salman T, Yildiz E, Yildiz I, Yavuzer D, Unlu M, Varol U, Akyol M, Yildiz Y, Bayoglu V, Kucukzeybek Y, Alacacioglu A
  • Quality of life in colorectal cancer patients: an Izmir Oncology Group (IZOG) study.J BUON. 2015 Jul-Aug;20(4):1015-22. Akyol M, Ulger E, Alacacioglu A, Kucukzeybek Y, Bayoglu V, Yildiz Y, Yildiz I, Salman T, Varol U, Demir L, Dirican A, Gumus Z, Oktay Tarhan M.
  • First-line cisplatin plus bolus 5- Fluorouracil combination in patients with locally advanced and metastatic esophageal cancer (Izmir Oncology Group study)Ahmet Alacacıoğlu, Mustafa Oktay Tarhan. Acta Oncol Tur. 2015; 48(1): 20-26 DOI: 10.5505/aot.2015.92408 Murat Akyol, Yüksel Küçükzeybek, Umut Varol, Ibrahim Yıldız, Suna Çokmert, Ibrahim Vedat Bayoğlu, Yaşar Yıldız, Lutfiye Demir, Alper Can, Ahmet Dirican
  • Prognostic value of mesothelin expression in patients with triple negative and HER2-positive breast cancers.Biomedicine & pharmacotherapy,2015 IV Bayoglu, BB Kucukzeybek, Y Kucukzeybek, U Varol, I Yildiz, A Alacacioglu, M Akyol, L Demir, A Dirican, Y Yildiz, T Salman, MO Tarhan.
  • Adjuvant Chemotherapy and Prognostic Factors in Stage II Colon CancerVarol Umut, Salman Tarik, Yildiz Ibrahim, Can Huseyin, Tarhan Mustafa Oktay Asian Pac J Cancer Prev vol 16, 2015, DOI:http://dx.doi.org/10.7314/APJ Kucukzeybek Yuksel, Dirican Ahmet, Demir Lutfiye, Yildirim Serkan, Akyol Murat, Yildiz Yasar, Bayoglu Ibrahim Vedat, Alacacioglu Ahmet,
  • D-dimer and international normalized ratio (INR) are correlated with tumor markers and disease stage in colorectal cancer patients.Cancer Biomark. 2015 Kilic L, Yildiz I, Sen FK, Erdem MG, Serilmez M, Keskin S, Ciftci R, Karabulut S, Ordu C, Duranyildiz D, Tas F.
  • Sexual satisfaction, anxiety, depression and quality of life among Turkish colorectal cancer patients (Izmır Oncology Group(IZOG) study.Tarhan Mustafa Oktay.Japanese journal of clinical oncology,2015. Akyol Murat, Ulger Eda, Alacacioglu Ahmet, Kucukzeybek Yuksel, Yildiz Yasar, Gumus Zehra, Yildiz Ibrahim, Salman Tarik, Varol Umut, Ayakdas Semra,
  • Effects of Tamoxifen on Anxiety, Depression, Quality of Life and Sexual Satisfaction in Premenopausal Breast Cancer Patients.Inci Alacacioglu, Mustafa Oktay Tarhan. Ahmet Alacacioglu, Eda Ulger, Umut Varol, Ibrahim Yildiz, Tarik Salman, Vedat Bayoglu, Ahmet Dirican, Murat Akyol, Yasar Yildiz, Yuksel Kucukzeybek,
  • Potential curative role of chemotherapy in patients with metastatic colorectal cancer who achieved a complete response to first-line chemotherapy.Acta Oncologica Turcica Varol Umut, Alacacioglu Ahmet, Yildiz Ibrahim, Tarhan Mustafa Oktay
  • Multiple arterial occlusions precipitated by platinum based chemotherapy in a patient with testicular seminomaJournal-Cardiovascular Surgery, 1, Doi: 10.5455/jcvs.20131×12 Sen Fatma, Karavelioglu Yusuf, Yildiz Ibrahim, Sahin Dilek, Bavbek Sevil